Physician profile
Patience Amune
NPI 1437908365
$2,592.49
in general payments reported to CMS, 2019-2025
20 companies · $2,169 in 2025
The $2,169 reported for 2025 was more than what 93% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $423 · 2025: $2,169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,560 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,560.22 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $564.75 | 2024-2025 | |
| Vanda Pharmaceuticals INC. | $282.53 | 2024-2025 | Fanapt |
| Otsuka America Pharmaceutical, INC. | $216.05 | 2024-2025 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $186.08 | 2024-2025 | Cobenfy |
| Axsome Therapeutics, INC. | $150.83 | 2024-2025 | Auvelity |
| Medtronic, INC. | $146.44 | 2025 | Symplicity G3 |
| Novo Nordisk INC | $140.81 | 2025 | Ozempic |
| Gilead Sciences, INC. | $129.64 | 2025 | Livdelzi |
| Astrazeneca Pharmaceuticals Lp | $117.00 | 2025 | Airsupra |
| Eisai INC. | $103.19 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $100.00 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $92.16 | 2024-2025 | Caplyta |
| Janssen Pharmaceuticals, INC | $85.39 | 2024-2025 | Spravato, Invega Sustenna |
| Genzyme Corporation | $68.34 | 2025 | |
| Neurocrine Biosciences, INC. | $57.07 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $42.60 | 2025 | Jornay Pm |
| Tris Pharma INC | $34.92 | 2024 | Dyanavel Xr |
| Corium, LLC | $32.13 | 2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $22.36 | 2024 | |
| Noven Therapeutics, LLC | $20.20 | 2025 | Xelstrym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patience Amune listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.